BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 8851639)

  • 1. On beyond urine: clinically useful assessment instruments in the treatment of drug dependence.
    Carroll KM; Rounsaville BJ
    Behav Res Ther; 2002 Nov; 40(11):1329-44. PubMed ID: 12384328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial.
    Santos GM; Ikeda J; Coffin P; Walker JE; Matheson T; McLaughlin M; Jain J; Vittinghoff E; Batki SL
    PLoS One; 2021; 16(7):e0254724. PubMed ID: 34265007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Power of automated algorithms for combining time-line follow-back and urine drug screening test results in stimulant-abuse clinical trials.
    Oden NL; VanVeldhuisen PC; Wakim PG; Trivedi MH; Somoza E; Lewis D
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):350-7. PubMed ID: 21854277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial functioning and cocaine use during treatment: strength of relationship depends on type of urine-testing method.
    Ghitza UE; Epstein DH; Preston KL
    Drug Alcohol Depend; 2007 Dec; 91(2-3):169-77. PubMed ID: 17624688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cocaine use with quantitative urinalysis and estimation of new uses.
    Preston KL; Silverman K; Schuster CR; Cone EJ
    Addiction; 1997 Jun; 92(6):717-27. PubMed ID: 9246799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies.
    Preston KL; Silverman K; Schuster CR; Cone EJ
    NIDA Res Monogr; 1997; 167():130-45. PubMed ID: 9243560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified quantitation of urinary benzoylecgonine in cocaine addiction research and for related pharmacotherapeutic trials.
    Peters JE; Chou JZ; Ho A; Reid K; Borg L; Kreek MJ
    Addiction; 1996 Nov; 91(11):1687-97. PubMed ID: 8972926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement properties of quantitative urine benzoylecgonine in clinical trials research.
    Delucchi KL; Jones RT; Batki SL
    Addiction; 1997 Mar; 92(3):297-302. PubMed ID: 9219391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative versus qualitative urinalysis for benzoylecgonine in clinical trials for the assessment of cocaine use.
    Li SH; Chiang CN; Tai BC; Marschke CK; Hawks RL
    Psychopharmacol Bull; 1995; 31(4):671-9. PubMed ID: 8851639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis.
    Jones RT
    NIDA Res Monogr; 1997; 175():221-34. PubMed ID: 9467801
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of quantitative urinalysis in monitoring cocaine use.
    Preston KL; Silverman K; Schuster CR; Cone EJ
    NIDA Res Monogr; 1997; 175():253-64. PubMed ID: 9467803
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.